Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small cell lung cancer (START): A randomized, double-blind, phase III trial

Michael DeGregorio; Lin Soe; Michael Wolf

doi:10.3978/j.issn.2072-1439.2014.05.15

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small cell lung cancer (START): A randomized, double-blind, phase III trial

Michael DeGregorio, Lin Soe, Michael Wolf

Hematology and Oncology

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	571-573
Number of pages	3
Journal	Journal of Thoracic Disease
Volume	6
Issue number	6
DOIs	https://doi.org/10.3978/j.issn.2072-1439.2014.05.15
State	Published - 2014

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.3978/j.issn.2072-1439.2014.05.15

Cite this

@article{c2f360ad68974d74a46c40cdece401c2,

title = "Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small cell lung cancer (START): A randomized, double-blind, phase III trial",

author = "Michael DeGregorio and Lin Soe and Michael Wolf",

year = "2014",

doi = "10.3978/j.issn.2072-1439.2014.05.15",

language = "English (US)",

volume = "6",

pages = "571--573",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "Pioneer Bioscience Publishing Company (PBPC)",

number = "6",

}

TY - JOUR

T1 - Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small cell lung cancer (START)

T2 - A randomized, double-blind, phase III trial

AU - DeGregorio, Michael

AU - Soe, Lin

AU - Wolf, Michael

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84904903954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904903954&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2072-1439.2014.05.15

DO - 10.3978/j.issn.2072-1439.2014.05.15

M3 - Article

AN - SCOPUS:84904903954

VL - 6

SP - 571

EP - 573

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

IS - 6

ER -

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small cell lung cancer (START): A randomized, double-blind, phase III trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this